Co-Authors
This is a "connection" page, showing publications co-authored by Vincent Calvez and Anne-Geneviève Marcelin.
Connection Strength
3.130
-
Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 May 10; 12(1):2824.
Score: 0.236
-
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. 2021 Jul; 83(1):119-145.
Score: 0.236
-
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 02 08; 12(1):844.
Score: 0.232
-
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients. J Antimicrob Chemother. 2019 05 01; 74(5):1368-1375.
Score: 0.205
-
Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases. J Clin Microbiol. 2018 06; 56(6).
Score: 0.192
-
Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load. J Clin Virol. 2017 11; 96:49-53.
Score: 0.184
-
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy. J Antimicrob Chemother. 2014 Mar; 69(3):753-6.
Score: 0.140
-
Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital. Clin Infect Dis. 2021 12 06; 73(11):e4064-e4072.
Score: 0.061
-
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clin Infect Dis. 2021 10 05; 73(7):e1762-e1765.
Score: 0.061
-
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. 2021 10; 83(4):e1-e3.
Score: 0.060
-
Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers. Clin Infect Dis. 2021 May 29.
Score: 0.059
-
In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface. Int J Mol Sci. 2021 Feb 08; 22(4).
Score: 0.058
-
Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value. Clin Microbiol Infect. 2021 07; 27(7):1056-1057.
Score: 0.058
-
The First Locally Acquired Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Healthcare Worker in the Paris Area. Clin Infect Dis. 2020 12 03; 71(9):e530-e531.
Score: 0.057
-
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int J Infect Dis. 2021 Jan; 102:10-13.
Score: 0.057
-
Medical features of COVID-19 and influenza infection: A comparative study in Paris, France. J Infect. 2021 02; 82(2):e36-e39.
Score: 0.056
-
Evolution of viral quasispecies during SARS-CoV-2 infection. Clin Microbiol Infect. 2020 Nov; 26(11):1560.e1-1560.e4.
Score: 0.056
-
Clinical presentation of Covid-19 in health care workers from a French University Hospital. J Infect. 2020 09; 81(3):e61-e63.
Score: 0.056
-
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect. 2021 01; 82(1):159-198.
Score: 0.055
-
Shared HCV Transmission Networks Among HIV-1-Positive and HIV-1-Negative Men Having Sex With Men by Ultradeep Sequencing. J Acquir Immune Defic Syndr. 2019 09 01; 82(1):105-110.
Score: 0.053
-
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017. Euro Surveill. 2019 Sep; 24(39).
Score: 0.053
-
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations. J Antimicrob Chemother. 2019 07 01; 74(7):2019-2023.
Score: 0.052
-
HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen. J Antimicrob Chemother. 2019 06 01; 74(6):1679-1692.
Score: 0.052
-
INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels. Open Forum Infect Dis. 2019 May; 6(5):ofz177.
Score: 0.051
-
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL Study. Pharmacotherapy. 2019 04; 39(4):514-520.
Score: 0.051
-
Caution is needed in interpreting HIV transmission chains by ultradeep sequencing. AIDS. 2019 03 15; 33(4):691-699.
Score: 0.051
-
Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 11 28; 67(12):1883-1889.
Score: 0.050
-
New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T). Chem Biol Drug Des. 2019 01; 93(1):50-59.
Score: 0.050
-
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing. Int J Antimicrob Agents. 2019 Jan; 53(1):80-83.
Score: 0.049
-
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants. PLoS One. 2018; 13(6):e0198334.
Score: 0.048
-
Bridging ß-Cyclodextrin Prevents Self-Inclusion, Promotes Supramolecular Polymerization, and Promotes Cooperative Interaction with Nucleic Acids. Angew Chem Int Ed Engl. 2018 06 25; 57(26):7753-7758.
Score: 0.048
-
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen. Clin Infect Dis. 2018 05 02; 66(10):1588-1594.
Score: 0.048
-
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance. J Antimicrob Chemother. 2018 05 01; 73(5):1158-1166.
Score: 0.048
-
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen. J Antimicrob Chemother. 2018 04 01; 73(4):1039-1044.
Score: 0.048
-
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir. J Antimicrob Chemother. 2018 Jan 01; 73(1):173-176.
Score: 0.047
-
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma. J Antimicrob Chemother. 2017 08 01; 72(8):2351-2354.
Score: 0.045
-
Addition of Etravirine Does Not Enhance the Initial Decline of HIV-1 RNA in Treatment-Experienced Patients Receiving Raltegravir. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):448-454.
Score: 0.045
-
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation. J Antimicrob Chemother. 2017 05 01; 72(5):1537-1539.
Score: 0.045
-
Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression. J Antimicrob Chemother. 2017 04 01; 72(4):1147-1151.
Score: 0.044
-
A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion. Clin Infect Dis. 2013 Sep; 57(5):745-55.
Score: 0.034